4.6 Review

Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review

Related references

Note: Only part of the references are listed.
Letter Gastroenterology & Hepatology

Six-month follow-up of gut microbiota richness in patients with COVID-19

Yanfei Chen et al.

Article Immunology

Metatranscriptomic Characterization of Coronavirus Disease 2019 Identified a Host Transcriptional Classifier Associated With Immune Signaling

Haocheng Zhang et al.

Summary: This study analyzed the metatranscriptomic characteristics of COVID-19 and non-COVID-19 pneumonia patients, revealing that COVID-19 patients have a disrupted airway microbiome with reduced alpha diversity, potential pathogenic microbes, and a unique immune-associated host transcriptional signature that could improve diagnosis and indicate disease severity.

CLINICAL INFECTIOUS DISEASES (2021)

Article Gastroenterology & Hepatology

Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19

Tao Zuo et al.

Summary: This study reveals active and prolonged 'quiescent' gastrointestinal infection of SARS-CoV-2 in patients with COVID-19, even without gastrointestinal manifestations and after recovery from respiratory infection. Patients with active SARS-CoV-2 gastrointestinal infection have a gut microbiota characterized by enrichment of opportunistic pathogens and an increased functional capacity for nucleotide and amino acid biosynthesis and carbohydrate metabolism.
Article Gastroenterology & Hepatology

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

Yun Kit Yeoh et al.

Summary: This study found that the gut microbiome composition was significantly altered in patients with COVID-19 compared to non-COVID-19 individuals, regardless of medication received. Certain gut commensals known for their immunomodulatory potential were underrepresented in patients and remained low even after disease resolution. Additionally, the altered gut microbiome composition correlated with disease severity and elevated levels of inflammatory cytokines and blood markers.
Review Immunology

The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes

Valentin Sencio et al.

Summary: The gut microbiota plays a critical role in pulmonary immunity and host defense against viral respiratory infections. Disease settings can profoundly impact the composition and function of the gut microbiota, leading to increased disease severity.

MUCOSAL IMMUNOLOGY (2021)

Article Allergy

SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome

Christian Rosas-Salazar et al.

Summary: This study found complex associations between SARS-CoV-2 infection and the URT microbiome in adults, with viral load potentially impacting bacterial abundance. Further research is needed to explore how these viral-bacterial interactions can affect the clinical progression of COVID-19.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

16S rRNA gene sequencing of rectal swab in patients affected by COVID-19

Antonio Mazzarelli et al.

Summary: COVID-19 patients show altered gut microbiota composition, with decreased microbial richness in ICU patients and increased Proteobacteria in infectious disease wards patients compared to controls.

PLOS ONE (2021)

Article Gastroenterology & Hepatology

Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections?

Jyoti Chhibber-Goel et al.

Summary: COVID-19 patients may have SARS-CoV-2 present in their nasopharyngeal and stool samples. The gut microbiota plays a crucial role in immune response and could be a significant factor in the prognosis of COVID-19.

GUT PATHOGENS (2021)

Article Environmental Sciences

Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing

Martina Rueca et al.

Summary: A study conducted microbial sequencing on 21 patients affected by COVID-19, revealing that patients with severe symptoms showed lower Chao1 and Shannon diversity indices, as well as specific microbial community loss.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Immunology

Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?

Carmela Nardelli et al.

Summary: SARS-CoV-2 infection leads to significant differences in the nasopharyngeal microbiome composition between patients and controls. The reduction of certain bacteria, such as Fusobacterium periodonticum (FP), may affect the pathogenesis of SARS-CoV-2 infection. Further research is needed to elucidate the specific role of FP in COVID-19.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Immunology

SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?

Indranil Chattopadhyay et al.

Summary: Research suggests that alterations in gut microbiome may play a crucial role in determining the clinical outcome of COVID-19 patients. Manipulating gut microbiota could lead to the development of effective therapeutic strategies against the immunopathogenesis and comorbidities of COVID-19.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Biology

Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults

Rong Xu et al.

Summary: This study conducted longitudinal analyses of throat and anal microbiomes in 35 COVID-19 patients and 19 healthy controls. Results showed lower bacterial diversity in COVID-19 patients, but observed a synchronous restoration of upper respiratory and gut microbiomes in some mild patients.

COMMUNICATIONS BIOLOGY (2021)

Review Immunology

The microbiota-mediated dietary and nutritional interventions for COVID-19

Amin Gasmi et al.

Summary: Scientists worldwide are searching for specific treatments for COVID-19, with dietary, nutritional, and lifestyle interventions showing potential to support healthy immune responses. Recent studies have explored the interactions between the airway and intestinal microbiota, antiviral host immunity, and the impact of various interventions on preventing severe outcomes of COVID-19.

CLINICAL IMMUNOLOGY (2021)

Review Nutrition & Dietetics

Modulation of gut microbiota protects against viral respiratory tract infections: a systematic review of animal and clinical studies

Hai Yun Shi et al.

Summary: Probiotics have shown to have a positive impact on the prevention and treatment of viral respiratory tract infections by modulating gut microbiota to enhance host immunity, decrease viral load, and alleviate symptoms. Further research is needed on next generation probiotics specific to different viral types for the prevention and treatment of emerging viral RTIs.

EUROPEAN JOURNAL OF NUTRITION (2021)

Article Immunology

Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai

Qing Miao et al.

Summary: In COVID-19 patients, a notable rate of superinfection was observed, especially in critically ill cases. Fungal co-infection is significantly associated with higher mortality rates, and the clinical benefit of metagenomic sequencing in guiding antimicrobial management warrants further investigation.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)

Article Multidisciplinary Sciences

Variability in digestive and respiratory tract Ace2 expression is associated with the microbiome

Sean T. Koester et al.

Summary: Patients with gastrointestinal symptoms of COVID-19 tend to have worse prognosis. The gene Ace2, expressed in the gut and encoding the host protein targeted by SARS-CoV-2, may play a role in mitigating COVID-19 severity. Research suggests that the microbiome could potentially modulate Ace2 expression, impacting COVID-19 infection risk and disease severity.

PLOS ONE (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition

Tzipi Braun et al.

Summary: Despite the rapid spread of COVID-19 around the world, a study on nasopharyngeal swab samples found that SARS-CoV-2 does not have a significant effect on the microbial community in the nasopharynx.

SCIENTIFIC REPORTS (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Medicine, General & Internal

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The article introduces PRISMA 2020, an updated reporting guideline for systematic reviews and meta-analyses.

PLOS MEDICINE (2021)

Article Immunology

Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Pseudomonas aeruginosa Chronic Colonizer

Jiuxin Qu et al.

Summary: The study found that a strong biofilm-forming Pseudomonas aeruginosa strain collected from a severe COVID-19 patient displayed specific epigenetic markers, which might enhance its antibiotic resistance and in vivo colonization ability in COVID-19 patients.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Microbiology

Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19

Maria Paz Ventero et al.

Summary: This study investigated the nasopharynx microbial community of patients with different severity levels of COVID-19, revealing differences in composition of specific OTUs and complexity of co-abundance networks. Taxa with differential abundances could potentially serve as biomarkers for COVID-19 severity, but validation with larger sample sizes is needed.

FRONTIERS IN MICROBIOLOGY (2021)

Article Biology

Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features

Longxian Lv et al.

Summary: The study reveals that gut mycobiota dysbiosis occurs in both COVID-19 patients and H1N1-infected patients, and this dysbiosis does not improve until patients are discharged and no longer require medical attention.

COMMUNICATIONS BIOLOGY (2021)

Article Medicine, General & Internal

Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients

Fengqiong Liu et al.

Summary: The study found that FMT treatment can improve gastrointestinal symptoms, regulate gut microbiota composition, and improve immune status in COVID-19 patients. Changes in B cells and increased microbial community richness were observed after FMT, indicating significant therapeutic effects on the disease.

JOURNAL OF MEDICAL CASE REPORTS (2021)

Article Gastroenterology & Hepatology

SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota

Harry Sokol et al.

Summary: This study utilized a macaque model to investigate the impact of SARS-CoV-2 infection on the gut microbiota, revealing significant changes in the composition and activity of the gut microbiota post-infection. Some alterations in the microbiota persisted even after the infection was resolved.

GUT MICROBES (2021)

Article Gastroenterology & Hepatology

Microbiota-derived short-chain fatty acids do not interfere with SARS-CoV-2 infection of human colonic samples

Livia Bitencourt Pascoal et al.

Summary: Studies show that SARS-CoV-2 infection alters microbiota and SCFAs production, but SCFAs have minimal impact on the infection of SARS-CoV-2 in the intestine.

GUT MICROBES (2021)

Editorial Material Gastroenterology & Hepatology

Evidence for Gastrointestinal Infection of SARS-CoV-2

Fei Xiao et al.

GASTROENTEROLOGY (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Editorial Material Medicine, General & Internal

Defining the Epidemiology of Covid-19-Studies Needed

Marc Lipsitch et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Immunology

Marked Changes in Gut Microbiota in Cardio-Surgical Intensive Care Patients: A Longitudinal Cohort Study

Heleen Aardema et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Letter Medicine, General & Internal

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Wenling Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Virology

Clinical characteristics of 3062 COVID-19 patients: A meta-analysis

Jieyun Zhu et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Article Virology

Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes

Mahesh Chemudupati et al.

JOURNAL OF VIROLOGY (2020)

Letter Critical Care Medicine

Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19

Alexandre Alanio et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Dermatology

COVID-19 associated pulmonary aspergillosis

Philipp Koehler et al.

MYCOSES (2020)

Review Immunology

COVID-19 pathophysiology: A review

Koichi Yuki et al.

CLINICAL IMMUNOLOGY (2020)

Article Biochemical Research Methods

Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients

Flavio De Maio et al.

BIOLOGICAL PROCEDURES ONLINE (2020)

Editorial Material Immunology

Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation?

Daniela Morniroli et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Immunology

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Yujun Tang et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Immunology

Antibiotics as Major Disruptors of Gut Microbiota

Jaime Ramirez et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Article Biology

Comparative ACE2 variation and primate COVID-19 risk

Amanda D. Melin et al.

COMMUNICATIONS BIOLOGY (2020)

Letter Infectious Diseases

Co-infections: potentially lethal and unexplored in COVID-19

Michael J. Cox et al.

LANCET MICROBE (2020)

Review Immunology

Microbes, metabolites, and the gut-lung axis

Anh Thu Dang et al.

MUCOSAL IMMUNOLOGY (2019)

Review Immunology

The influence of the microbiome on respiratory health

Tomasz P. Wypych et al.

NATURE IMMUNOLOGY (2019)

Review Biotechnology & Applied Microbiology

Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective

Ravichandra Vemuri et al.

BIOMED RESEARCH INTERNATIONAL (2018)

Review Immunology

Role of the intestinal microbiota in the immunomodulation of influenza virus infection

Chi-Jene Chen et al.

MICROBES AND INFECTION (2017)

Review Microbiology

The microbiota of the respiratory tract: gatekeeper to respiratory health

Wing Ho Man et al.

NATURE REVIEWS MICROBIOLOGY (2017)

Review Microbiology

Optimizing methods and dodging pitfalls in microbiome research

Dorothy Kim et al.

MICROBIOME (2017)

Article Multidisciplinary Sciences

Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients

Andrea Ticinesi et al.

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

Influence of H7N9 virus infection and associated treatment on human gut microbiota

Nan Qin et al.

SCIENTIFIC REPORTS (2015)

Article Health Care Sciences & Services

Guidance for conducting systematic scoping reviews

Micah D. J. Peters et al.

INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)

Article Virology

Viruses and the Microbiota

Christopher M. Robinson et al.

ANNUAL REVIEW OF VIROLOGY, VOL 1 (2014)

Article Multidisciplinary Sciences

ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation

Tatsuo Hashimoto et al.

NATURE (2012)

Article Multidisciplinary Sciences

Microbiota regulates immune defense against respiratory tract influenza A virus infection

Takeshi Ichinohe et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)